The Lancet
Elena Bellafante is a seasoned researcher and editor in the fields of metabolism, diabetes, and medical imaging with extensive experience in scientific publishing. Currently serving as Deputy Editor at eClinicalMedicine, the Lancet Discovery since April 2023, Elena previously held the position of Senior Scientific Editor at Med, Cell Press from June 2020 to April 2023. Prior roles include Associate Editor at both Nature Metabolism and Nature Communications, where Elena managed manuscripts related to metabolism, kidney physiology, and diagnostic imaging. Elena's research background includes a Marie Curie Fellowship at King's College London, focusing on glucose metabolism during pregnancy, and multiple research associate positions exploring hormonal influences on islet function and intestinal health. Elena holds a PhD in Biomolecular Science from The Open University and master's and bachelor's degrees in Biochemistry and Molecular Biology and Biological Science, respectively, from Università Politecnica delle Marche.
The Lancet
The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.